Boyuan Capital

Boyuan Capital is an investment platform founded in 2021 and operates as the corporate venture capital arm of the Bosch Group, based in Shanghai, China. The firm is dedicated to advancing China's deep science and technology sector, with a primary focus on industries such as sustainable transportation, intelligent manufacturing, the Internet of Things, artificial intelligence, semiconductors, and carbon neutral technologies. By targeting these key areas, Boyuan Capital aims to foster innovation and support the development of cutting-edge solutions that address pressing global challenges.

Dr. Li Han

Vice President

Zhu Lin

Managing Partner and CEO

30 past transactions

Oukejian

Series A in 2025
Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

U Power

Series B in 2024
U Power is an intelligent electric vehicle company based in Xuhui District, Shanghai, China. Founded in 2021, the company focuses on developing vehicles tailored for specific scenarios, allowing clients to customize cars through its standardized UP super chassis. U Power aims to facilitate the implementation of Car as a Service (CaaS) capabilities, empowering clients to integrate automotive solutions into their projects effectively.

Guangdong Xinyue

Series A in 2024
Xinyueneng manufactures silicon carbide chips and conducts research and development in the automotive and industrial control industries.

GasGene

Seed Round in 2024
GasGene ferments industrial waste gas to generate bulk chemicals.

Jiuyou Airlines

Series A in 2023
Jiuyou aircraft is a high-tech company specializing in the research and development, manufacturing, and after-sales support of aircraft parts and composite products.

Rigen Biotech

Series B in 2023
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.

Minieye

Series E in 2023
MINIEYE specializes in developing advanced vehicle visual sensing systems aimed at enhancing road safety and driver awareness. The company's technology detects various traffic elements such as vehicles, pedestrians, lanes, and traffic signals, helping drivers navigate more effectively. Additionally, MINIEYE incorporates in-cabin sensing capabilities that monitor the behavior and conditions of both drivers and passengers, analyzing factors like eyelid movement and body orientation. By leveraging deep learning algorithms, MINIEYE's systems are designed to function reliably in challenging weather and lighting conditions, thereby supporting safer driving and reducing the likelihood of accidents. The company's mission focuses on improving vehicle automation while prioritizing the safety of all road users.

AIMIRA Innovation Technology

Seed Round in 2023
AIMIRA Innovation Technology is an AI-based medical technology company that offers diagnosis, aesthetic plastic surgery, and anti-aging medicine.

DeepKinase

Series A in 2023
DeepKinase is a biotechnology company that specializes in clinical proteomics, utilizing its patented DoTK (Deep Omics of Tyrosine Kinase) platform. The company focuses on diagnosing various conditions, including tumors, immune system disorders, and neurodegenerative diseases. By leveraging advanced proteomics technology, DeepKinase aims to enhance diagnostic accuracy, enabling healthcare providers to offer more precise assessments and treatment strategies.

AutoCore

Series A in 2023
AutoCore is a provider of intelligent mobility software and solutions for automotive electrical and electronic architecture. The company focuses on developing an automotive middleware platform that supports next-generation vehicles, offering tailored operating systems and autonomous driving software for various EEA computing platforms. By assisting Original Equipment Manufacturers (OEMs) and Tier 1 suppliers throughout the entire life cycle, from design to production, AutoCore plays a critical role in advancing automotive technology and innovation.

Shiyu Technology

Seed Round in 2023
Shiyu Technology specialized in innovative research and development of automotive thermal domain control systems. Its products and services include thermal management, heat pumps, air conditioning, and cloud-based data and control algorithms.

Guangdong Xinjuneng

Series C in 2022
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.

Health Gene Technologies

Series C in 2022
Health Gene Technologies provides premium solutions for multiplexed nucleic acid detection. Based on the high-resolution Capillary Electrophoresis (CE) Platform, HGT has independently developed a series of nucleic acid testing products, established a set of matured clinical nucleic acid testing solutions. Health Gene Technologies provides complete testing solutions for forensic DNA samples. It includes reagents and equipment required in the entire laboratory process.

Innogen Pharmaceutical

Venture Round in 2022
Innogen Pharmaceutical Technology is an international biopharmaceutical company specializing in the development and manufacturing of innovative drugs. The company utilizes advanced genetic engineering and recombinant protein biopharmaceutical processes to create new therapies. Its primary focus is on addressing the treatment needs of patients suffering from diabetic metabolic diseases and significant central nervous system disorders. Through its research and development efforts, Innogen aims to deliver effective solutions that enhance patient care and improve health outcomes.

SiEngine Technology

Series A in 2022
SiEngine Technology specializes in the development of electronic chips for the automotive industry. The company focuses on creating advanced automotive solutions, including smart cockpit System on a Chip (SoC) and control chips designed for autonomous driving. By integrating these technologies, SiEngine aims to enhance the driving experience, making it more intelligent and efficient for users.

Yuce Biotechnology

Series A in 2022
Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies.

Yueer Gene

Series B in 2022
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.

Brise Pharma

Seed Round in 2022
Brise Pharma is a biopharmaceutical company dedicated to developing innovative drugs aimed at treating pain. The company focuses on creating highly differentiated analgesic treatments for various debilitating pain conditions, particularly targeting migraine, neuropathic, and musculoskeletal pain. By addressing significant unmet needs in pain management, Brise Pharma aims to enable healthcare providers to offer safe, effective, and accessible pain relief solutions for patients worldwide who suffer from poorly managed pain conditions.

Black Sesame Technologies

Venture Round in 2022
Black Sesame Technologies is an AI digital imaging technology firm founded in 2016, with locations in Silicon Valley and Shanghai. The company specializes in developing solutions for real-world AI challenges, focusing on image processing, computing images, and embedded sensing platforms. It provides advanced algorithms for applications in smartphones, autonomous driving, and various consumer electronics. The firm conducts extensive research and development, including core algorithm development, ASIC design, and software systems for advanced driver-assistance systems (ADAS). Black Sesame Technologies is committed to innovation, quality, and reliable service, leveraging the extensive industry experience of its team members. The company has designed automotive-grade system-on-chips (SoCs), including the high-computing Huashan Series and the cross-domain Wudang Series, aimed at enhancing intelligent vehicle solutions and driving the future of mobility.

TopOlefin Technology

Series A in 2022
TopOlefin Technology specializes in the research, development, and production of advanced polymer materials, with a focus on high-end optical resins. The company is dedicated to creating products characterized by high transparency, high refractive index, and strong gas barrier properties. These innovative materials find applications across various industries, including optical lenses, medical packaging, and consumer packaging. By prioritizing green and intelligent design, TopOlefin Technology aims to deliver high-quality resin solutions that meet the diverse needs of its clients.

Wangli Technology

Series A in 2021
Wangli Technology is a digital therapy technology platform for mental illness focusing on exploring the field of human brain and spirit.

Yizhun Intelligent

Series C in 2021
Yizhun AI is an artificial intelligence and robotics company focused on developing advanced medical imaging technology. Its primary objective is to enhance the detection of nodules and tumors in the lungs and mammary glands. By leveraging artificial intelligence, Yizhun AI's technology significantly accelerates the identification of malignant entities, thereby assisting healthcare professionals in making accurate diagnoses. Through its innovative solutions, the company aims to improve patient outcomes and streamline the diagnostic process in the medical field.

BestCovered

Series A in 2021
BestCovered is a company focused on developing digital screening tools aimed at early detection and intervention for Alzheimer's disease. By leveraging artificial intelligence technologies, including speech analysis, gesture recognition, and natural language processing, BestCovered creates cognitive impairment risk assessment tools. These tools enable hospitals to achieve high prediction accuracy for Alzheimer's, facilitating timely care for patients. Additionally, BestCovered offers systematic multi-dimensional activation courses designed to help individuals maintain a flexible mind, further contributing to cognitive health and well-being.

LaNova Medicines

Series A in 2021
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.

Vega Technology

Venture Round in 2020
Vega Technology engages in the development of digital intelligent high-end special equipment. The company develops precision CNC, intelligent manufacturing, robot, industrial laser, visual inspection, Internet of things, structure and software design, which are widely used in semiconductor, PCB, SMT, 3C high precision metal processing, and other industrial fields.

Ark Biosciences

Venture Round in 2020
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.

Exegenesis Bio

Seed Round in 2020
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Heyuan Biotechnology

Series C in 2020
Heyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services. They offer gene therapy vectors, gene function research, drug targets, and efficacy for the basic research of gene therapy research, among other services.

BGI

Post in 2020
BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Sigma Squares Tech

Seed Round in 2019
Sigma Squares Tech focuses on developing automated manufacturing systems and industrial automation solutions. The company specializes in computer vision technologies and offers cloud-based platforms that analyze significant volumes of industrial data during the manufacturing process. By providing integrated analytical and control solutions, Sigma Squares Tech aims to enhance the efficiency and intelligence of small and medium-sized manufacturing companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.